197 related articles for article (PubMed ID: 32276307)
1. Circulating miR-320a as a Predictive Biomarker for Left Ventricular Remodelling in STEMI Patients Undergoing Primary Percutaneous Coronary Intervention.
Galeano-Otero I; Del Toro R; Guisado A; Díaz I; Mayoral-González I; Guerrero-Márquez F; Gutiérrez-Carretero E; Casquero-Domínguez S; Díaz-de la Llera L; Barón-Esquivias G; Jiménez-Navarro M; Smani T; Ordóñez-Fernández A
J Clin Med; 2020 Apr; 9(4):. PubMed ID: 32276307
[TBL] [Abstract][Full Text] [Related]
2. Predicted Value of MicroRNAs, Vascular Endothelial Growth Factor, and Intermediate Monocytes in the Left Adverse Ventricular Remodeling in Revascularized ST-Segment Elevation Myocardial Infarction Patients.
Del Toro R; Galeano-Otero I; Bevilacqua E; Guerrero-Márquez F; Falcon D; Guisado-Rasco A; Díaz-de la Llera L; Barón-Esquivias G; Smani T; Ordóñez-Fernández A
Front Cardiovasc Med; 2022; 9():777717. PubMed ID: 35402537
[TBL] [Abstract][Full Text] [Related]
3. Kinetics Analysis of Circulating MicroRNAs Unveils Markers of Failed Myocardial Reperfusion.
Coelho-Lima J; Mohammed A; Cormack S; Jones S; Ali A; Panahi P; Barter M; Bagnall A; Ali S; Young D; Spyridopoulos I
Clin Chem; 2020 Jan; 66(1):247-256. PubMed ID: 31672851
[TBL] [Abstract][Full Text] [Related]
4. [Index of microcirculatory resistance is associated with left ventricular remodeling in patients with acute anterior ST-segment elevation myocardial infarction undergoing emergency primary percutaneous coronary intervention].
Wang F; Liang F; Li N; Wang X; Han J; Guo L
Beijing Da Xue Xue Bao Yi Xue Ban; 2024 Feb; 56(1):150-156. PubMed ID: 38318910
[TBL] [Abstract][Full Text] [Related]
5. Visit-to-visit fasting plasma glucose variability is associated with left ventricular adverse remodeling in diabetic patients with STEMI.
Yang CD; Shen Y; Ding FH; Yang ZK; Hu J; Shen WF; Zhang RY; Lu L; Wang XQ
Cardiovasc Diabetol; 2020 Sep; 19(1):131. PubMed ID: 32878604
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of Initial Left Ventricular Remodeling in Patients With Reperfused STEMI.
Rodriguez-Palomares JF; Gavara J; Ferreira-González I; Valente F; Rios C; Rodríguez-García J; Bonanad C; García Del Blanco B; Miñana G; Mutuberria M; Nuñez J; Barrabés J; Evangelista A; Bodí V; García-Dorado D
JACC Cardiovasc Imaging; 2019 Dec; 12(12):2445-2456. PubMed ID: 31202752
[TBL] [Abstract][Full Text] [Related]
7. Profiling and validation of circulating microRNAs for cardiovascular events in patients presenting with ST-segment elevation myocardial infarction.
Jakob P; Kacprowski T; Briand-Schumacher S; Heg D; Klingenberg R; Stähli BE; Jaguszewski M; Rodondi N; Nanchen D; Räber L; Vogt P; Mach F; Windecker S; Völker U; Matter CM; Lüscher TF; Landmesser U
Eur Heart J; 2017 Feb; 38(7):511-515. PubMed ID: 28011706
[TBL] [Abstract][Full Text] [Related]
8. LncRNA MALAT1 functions as a biomarker of no-reflow phenomenon in ST-segment elevation myocardial infarction patients receiving primary percutaneous coronary intervention.
Yang X; Dai R; Qin Z; Cai R; Xu Y; Su Q
Sci Rep; 2022 Feb; 12(1):3294. PubMed ID: 35228564
[TBL] [Abstract][Full Text] [Related]
9. Non-Contrast Cine Cardiac Magnetic Resonance Derived-Radiomics for the Prediction of Left Ventricular Adverse Remodeling in Patients With ST-Segment Elevation Myocardial Infarction.
A X; Liu M; Chen T; Chen F; Qian G; Zhang Y; Chen Y
Korean J Radiol; 2023 Sep; 24(9):827-837. PubMed ID: 37634638
[TBL] [Abstract][Full Text] [Related]
10. Circulating microRNAs are new and sensitive biomarkers of myocardial infarction.
D'Alessandra Y; Devanna P; Limana F; Straino S; Di Carlo A; Brambilla PG; Rubino M; Carena MC; Spazzafumo L; De Simone M; Micheli B; Biglioli P; Achilli F; Martelli F; Maggiolini S; Marenzi G; Pompilio G; Capogrossi MC
Eur Heart J; 2010 Nov; 31(22):2765-73. PubMed ID: 20534597
[TBL] [Abstract][Full Text] [Related]
11. Circulating miR-122-5p/miR-133b Ratio Is a Specific Early Prognostic Biomarker in Acute Myocardial Infarction.
Cortez-Dias N; Costa MC; Carrilho-Ferreira P; Silva D; Jorge C; Calisto C; Pessoa T; Robalo Martins S; de Sousa JC; da Silva PC; Fiúza M; Diogo AN; Pinto FJ; Enguita FJ
Circ J; 2016 Sep; 80(10):2183-91. PubMed ID: 27593229
[TBL] [Abstract][Full Text] [Related]
12. Exosomal miR-152-5p and miR-3681-5p function as potential biomarkers for ST-segment elevation myocardial infarction.
Chen X; Huang F; Liu Y; Liu S; Tan G
Clinics (Sao Paulo); 2022; 77():100038. PubMed ID: 35751950
[TBL] [Abstract][Full Text] [Related]
13. Circulating miR-660-5p is associated with no-reflow phenomenon in patients with ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Zhang J; He L
Anatol J Cardiol; 2021 May; 25(5):323-329. PubMed ID: 33960307
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
[TBL] [Abstract][Full Text] [Related]
15. Left ventricular myocardial work in the culprit vessel territory and impact on left ventricular remodelling in patients with ST-segment elevation myocardial infarction after primary percutaneous coronary intervention.
Lustosa RP; Fortuni F; van der Bijl P; Goedemans L; El Mahdiui M; Montero-Cabezas JM; Kostyukevich MV; Ajmone Marsan N; Bax JJ; Delgado V; Knuuti J
Eur Heart J Cardiovasc Imaging; 2021 Feb; 22(3):339-347. PubMed ID: 32642755
[TBL] [Abstract][Full Text] [Related]
16. Relationship between TRAIL and Left Ventricular Ejection Fraction in Patients with ST-Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention.
Teringova E; Kozel M; Knot J; Kocka V; Benesova K; Tousek P
Biomed Res Int; 2018; 2018():3709084. PubMed ID: 30112383
[TBL] [Abstract][Full Text] [Related]
17. Circulating miR-1254 predicts ventricular remodeling in patients with ST-Segment-Elevation Myocardial Infarction: A cardiovascular magnetic resonance study.
de Gonzalo-Calvo D; Cediel G; Bär C; Núñez J; Revuelta-Lopez E; Gavara J; Ríos-Navarro C; Llorente-Cortes V; Bodí V; Thum T; Bayes-Genis A
Sci Rep; 2018 Oct; 8(1):15115. PubMed ID: 30310086
[TBL] [Abstract][Full Text] [Related]
18. Relationship between circulating miRNA-30e and no-reflow phenomenon in STEMI patients undergoing primary coronary intervention.
Su Q; Ye Z; Sun Y; Yang H; Li L
Scand J Clin Lab Invest; 2018 Jul; 78(4):318-324. PubMed ID: 29703083
[TBL] [Abstract][Full Text] [Related]
19. Relation of circulating MicroRNA-133a concentrations with myocardial damage and clinical prognosis in ST-elevation myocardial infarction.
Eitel I; Adams V; Dieterich P; Fuernau G; de Waha S; Desch S; Schuler G; Thiele H
Am Heart J; 2012 Nov; 164(5):706-14. PubMed ID: 23137501
[TBL] [Abstract][Full Text] [Related]
20. Assessment of the Efficacy and Safety of Early Intracoronary Nicorandil Administration in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
Gupta H; Parihar S; Tripathi VD
Cureus; 2022 May; 14(5):e25349. PubMed ID: 35761910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
